We were delighted to showcase the EXHALYZER®D at the European Cystic Fibrosis Society (ECFS) conference in Milan in June. The EXHALYZER®D is a well-known and valuable lung function testing device in the field of cystic fibrosis. Thanks to its ability to measure lung function more sensitively than traditional spirometry and to detect early lung disease progression and ventilation inhomogeneity, it is a key tool in cystic fibrosis treatment and clinical trials.
EXHALYZER D at ECFS Congress
